Effect of Antacid on the Pharmacokinetics of Extended-Release Formulations of Tolterodine and Oxybutynin

被引：0

作者：

Gayatri Sathyan

Roger R. Dmochowski

Rodney A. Appell

Cindy Guo

Suneel K. Gupta

机构：

[1] ALZA Corporation,Department of Clinical Pharmacology

[2] Vanderbilt University Medical Center,Department of Urologic Surgery

[3] Baylor College of Medicine,Scott Department of Urology

来源：

Clinical Pharmacokinetics | 2004年 / 43卷

关键词：

Drug Release; Oxybutynin; Tolterodine; Poor Metaboliser; Active Moiety;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1059 / 1068

页数：9

共 50 条

[1] Effect of antacid on the pharmacokinetics of extended-release formulations of tolterodine and oxybutynin
Sathyan, G
Dmochowski, RR
Appel, RA
Guo, C
Gupta, SK
CLINICAL PHARMACOKINETICS, 2004, 43 (14) : 1059 - 1068
[2] In vivo study of the effect of antacid on extended-release formulations of oxybutynin and tolterodine.
Dmochowski, R
Sathyan, G
Ye, C
Gupta, SK
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : S39 - S39
[3] Effect of a proton pump inhibitor on the pharmacokinetics of extended-release formulations of oxybutynin and tolterodine
MacDiarmid, S
JOURNAL OF UROLOGY, 2004, 171 (04): : 140 - 140
[4] Effect of the proton pump inhibitor omeprazole on the pharmacokinetics of extended-release formulations of oxybutynin and tolterodine
Dmochowski, R
Chen, A
Sathyan, G
MacDiarmid, S
Gidwani, S
Gupta, S
JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (08): : 961 - 968
[5] Comparison of gastrointestinal effects with extended-release formulations of oxybutynin and tolterodine
Peters, KM
JOURNAL OF UROLOGY, 2004, 171 (04): : 136 - 136
[6] Treatment of overactive bladder: A model comparing extended-release formulations of tolterodine and oxybutynin
Perfetto, EM
Subedi, P
Jumadilova, Z
AMERICAN JOURNAL OF MANAGED CARE, 2005, 11 (04): : S150 - S157
[7] Extended-release oxybutynin and tolterodine treat overactive bladder
Ables, AZ
JOURNAL OF FAMILY PRACTICE, 2003, 52 (11): : 829 - 830
[8] GI effects are not a concern with extended-release formulations of oxybutynin and tolterodine in older and younger women.
Appell, R
Kell, S
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S25 - S25
[9] Comparison of dry mouth in women treated with extended-release formulations of oxybutynin or tolterodine for overactive bladder
Armstrong R.B.
Luber K.M.
Peters K.M.
International Urology and Nephrology, 2005, 37 (2) : 247 - 252
[10] Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence
Dyfrig A. Hughes
Dominique Dubois
PharmacoEconomics, 2004, 22 : 1047 - 1059

← 1 2 3 4 5 →